In Vitro Fertilization (IVF) Market: AI-Driven Embryo Selection, Time-Lapse Incubator Trends, & Industry Growth Outlook

According to IMARC Group's latest research publication, The global in vitro fertilization market size was valued at USD 28.1 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 51.3 Billion by 2034, exhibiting a CAGR of 6.90% during 2026-2034.

How AI is Reshaping the Future of In Vitro Fertilization Market

• Embryo Selection and Viability Prediction: Machine learning algorithms analyze time-lapse imaging and morphological data to identify the most viable embryos for implantation.
• Personalized Ovarian Stimulation Protocols: AI-powered forecasting systems analyze patient demographics, medical history, hormone levels, and previous treatment responses to optimize stimulation medication dosing.
• Sperm Quality Assessment and Selection: Computer-assisted sperm analysis enhanced with deep learning evaluates morphology, motility, and concentration with exceptional precision and consistency.

Download the Most Recent 2026 Market Forecasts

In Vitro Fertilization Industry Overview

The IVF landscape is experiencing transformative change as governments worldwide address declining birth rates through policy interventions. The U.S. administration announced groundbreaking initiatives including an 84% discount on common fertility medications through TrumpRx.gov starting early this year, while new employer benefit frameworks allow standalone fertility coverage similar to dental and vision insurance.

In Vitro Fertilization Market Trends & Drivers

Declining fertility rates and rising infertility prevalence are fundamentally reshaping reproductive healthcare demand. The U.S. total fertility rate dropped to a historic low of 1.599, falling below the 2.1 replacement level necessary for population sustainability. An estimated 17.5% of people globally experience infertility during their reproductive years, with about 13.4% of American women aged 15-49 facing impaired fertility.

Medical tourism is revolutionizing IVF accessibility, with the fertility tourism sector projected to reach USD 6.18 Billion driven by dramatic cost differentials and legal variations across borders. Turkey leads as a preferred destination with over 140 IVF clinics offering treatments from USD 2,800, while Spain, Greece, and Mexico attract international patients with comprehensive donor programs and progressive legal frameworks.

Expanding insurance coverage and innovative financing models are reducing financial barriers that have historically limited IVF access. While only 32% of U.S. employers currently cover IVF treatments, recent regulatory changes enabling standalone fertility benefits promise broader workplace coverage similar to successful dental and vision insurance models.

Leading Companies Operating in the Global In Vitro Fertilization Industry:

• Boston IVF
• CooperSurgical Inc. (The Cooper Companies Inc.)
• Esco Micro Pte. Ltd
• FUJIFILM Holdings Corporation
• Genea Pty Limited
• Hamilton Thorne Ltd.
• SAFE Fertility Center
• Vitrolife AB

In Vitro Fertilization Market Report Segmentation:

By Product:

• Reagent
• Cryopreservation Media
• Embryo Culture Media
• Ovum Processing Media
• Sperm Processing Media
• Instrument (62.6% market share)
• Imaging Systems
• Incubators
• Cryosystems
• IVF Cabinet
• Ovum Aspiration Pump
• Sperm Separation Systems
• Micromanipulator Systems
• Others
• Accessories

Instruments represent the largest segment due to their critical role in ensuring precise, efficient procedures and improving success rates through advanced technologies like time-lapse monitoring and automated systems.

By Procedure Type:

• Fresh Donor
• Frozen Donor
• Fresh Non-donor
• Frozen Non-donor (59.7% market share)

The frozen non-donor segment dominates due to improved cryopreservation techniques, particularly vitrification, which enhance embryo survival rates and offer greater scheduling flexibility.

By Cycle Type:

• Conventional IVF
• IVF with ICSI (43.0% market share)
• IVF with Donor Eggs

IVF with intracytoplasmic sperm injection leads the market as the most effective solution for severe male infertility cases, with precision micromanipulation significantly improving fertilization rates.

By End User:

• Fertility Clinics (63.9% market share)
• Hospitals
• Others

Fertility clinics dominate through specialized expertise, advanced facilities, personalized treatment protocols, and comprehensive services including genetic testing and donor programs.

Regional Insights:

• North America (United States, Canada)
• Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Europe exhibits clear market dominance due to favorable regulations, advanced healthcare infrastructure, comprehensive insurance coverage, progressive cultural attitudes toward fertility treatments, and competitive pricing that attracts international medical tourism.

Recent News and Developments in In Vitro Fertilization Market

• December 2025: INVO Fertility completed the acquisition of Family Beginnings fertility clinic in Indianapolis for USD 760,000, expanding its geographic footprint across the Midwest.
• October 2025: The Trump Administration announced a landmark IVF initiative including an 84% discount on EMD Serono fertility medications (Gonal-f, Ovidrel, Cetrotide) available through TrumpRx.gov.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.